The effect of vitamin D status on the occurrence of Kawasaki Disease: a meta-analysis

被引:0
作者
Zhang, Haixiang [1 ,2 ]
Jiao, Fuyong [3 ]
Wang, Jiaojiao [1 ,4 ]
Xu, Cuixiang [1 ,2 ]
Zhang, Kejin [1 ,5 ]
机构
[1] Shaanxi Prov Peoples Hosp, Shaanxi Prov Key Lab Infect & Immune Dis, 256 Youyi West Rd, Xian 710068, Shaanxi, Peoples R China
[2] Shaanxi Prov Peoples Hosp, Shaanxi Engn Res Ctr Cell Immunol, Xian 710068, Peoples R China
[3] Shaanxi Prov Peoples Hosp, Shaanxi Prov Kawasaki Dis Treatment Ctr, Childrens Hosp, Xian 710068, Peoples R China
[4] Yanan Univ, Sch Med, Dept Med, Yanan 716000, Peoples R China
[5] Northwest Univ, Inst Populat & Hlth, Coll Life Sci, Dept Biol Sci, Xian 710069, Peoples R China
关键词
Kawasaki disease; Vitamin D; 25-hydroxyvitamin D; Coronary artery lesion; RISK;
D O I
10.1186/s12887-024-04768-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim The relationship between vitamin D status and Kawasaki Disease (KD), as well as coronary artery lesion (CAL), has yet to be established. Methods A meta-analysis was conducted to assess the correlation between vitamin D status and KD, as well as the impact of vitamin D status on the progression of KD into CAL. Results The meta-analysis revealed a consistent and significant association between serum 25(OH)D level and the occurrence KD (studies N = 22; z = -3.51, P < 0.001). Patients with KD had markedly lower levels of vitamin D than healthy controls (SMD: -1.30 ng/mL, 95%CI: -2.05 to -0.55 ng/mL). Conclusion The study provided evidence supporting a significant association between lower serum vitamin D levels and the occurrence of KD, particularly within the Chinese population. However, the findings did not suggest a direct impact of vitamin D on the development of CAL in KD patients.
引用
收藏
页数:9
相关论文
共 56 条
[1]   Significance of serum 25-hydroxyvitamin D3 and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in children [J].
An, Xinjiang ;
Fu, Mingyu ;
Tian, Jing ;
Xue, Ying ;
Xu, Hui .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (03) :1476-1480
[3]   Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) [J].
Ayusawa, M ;
Sonobe, T ;
Uemura, S ;
Ogawa, S ;
Nakamura, Y ;
Kiyosawa, N ;
Ishii, M ;
Harada, K .
PEDIATRICS INTERNATIONAL, 2005, 47 (02) :232-234
[4]   VITAMIN D IN HEALTHY TUNISIAN POPULATION: PRELIMINARY RESULTS [J].
Bahlous, Afef ;
Krir, Asma ;
Mrad, Mehdi ;
Bouksila, Mouna ;
Kalai, Safa ;
Kilani, Osman ;
El Kateb, Elhem Cheour ;
Sahli, Hela ;
Laadhari, Nizar .
JOURNAL OF MEDICAL BIOCHEMISTRY, 2022, 41 (02) :168-175
[5]   Kawasaki disease [J].
Baker, Annette L. ;
Newburger, Jane W. .
CIRCULATION, 2008, 118 (07) :E110-E112
[6]   How to perform a meta-analysis with R: a practical tutorial [J].
Balduzzi, Sara ;
Ruecker, Gerta ;
Schwarzer, Guido .
EVIDENCE-BASED MENTAL HEALTH, 2019, 22 (04) :153-160
[7]   Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti-Inflammatory [J].
Bishop, Emma L. ;
Ismailova, Aiten ;
Dimeloe, Sarah ;
Hewison, Martin ;
White, John H. .
JBMR PLUS, 2021, 5 (01)
[8]   Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic [J].
Chakhtoura, M. ;
Napoli, N. ;
Fuleihan, G. El Hajj .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 109
[9]  
Chen X-H., 2019, Chinese J Woman Child Health Res, V30, P4
[10]   Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3 [J].
Chen, Yan-Li ;
Wang, Juan-Li ;
Li, Wei-Qin .
EUROPEAN JOURNAL OF PEDIATRICS, 2014, 173 (11) :1467-1471